NEW YORK (GenomeWeb) – Interleukin Genetics reported today that its revenues for the second quarter were $376,051 compared to $528,595 in the year-ago period, marking a 29 percent decrease.

The company attributed the revenue decrease during the three months ended June 30 to fewer weight management genetic test kits returned for processing through Access Business Group's promotional bundle program.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Human Longevity alleges that Craig Venter stole trade secrets in a lawsuit filed against the J. Craig Venter Institute.

A new paper critiques the analysis and conclusions of the Atacama mummy genome sequencing study.

In PLOS this week: transcription levels linked to uracil mutations, transcriptomic analysis of medicinal leech, and more.

An Associated Press poll finds that most US adults say they'd want to know whether they carried a gene variant predisposing them to an incurable disease.